Clari Vest Asset Management LLC Nurix Therapeutics, Inc. Transaction History
Clari Vest Asset Management LLC
- $1 Billion
- Q3 2024
A detailed history of Clari Vest Asset Management LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 63,149 shares of NRIX stock, worth $656,118. This represents 0.14% of its overall portfolio holdings.
Number of Shares
63,149
Previous 63,149
-0.0%
Holding current value
$656,118
Previous $1.32 Million
7.59%
% of portfolio
0.14%
Previous 0.14%
Shares
7 transactions
Others Institutions Holding NRIX
# of Institutions
175Shares Held
79.3MCall Options Held
126KPut Options Held
11.3K-
Black Rock Inc. New York, NY6.82MShares$70.9 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.06MShares$63 Million2.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.47MShares$46.4 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.95MShares$41 Million4.19% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$40.3 Million0.45% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $490M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...